195 related articles for article (PubMed ID: 12827452)
21. Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling.
Beristain E; Martínez-Bouzas C; Guerra I; Viguera N; Moreno J; Ibañez E; Díez J; Rodríguez F; Mallabiabarrena G; Luján S; Gorostiaga J; De Pablo JL; Mendizabal JL; Tejada MI
Breast Cancer Res Treat; 2007 Dec; 106(2):255-62. PubMed ID: 17262179
[TBL] [Abstract][Full Text] [Related]
22. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
23. Novel germline BRCA1 and BRCA2 mutations in breast and breast/ovarian cancer families from the Czech Republic.
Machackova E; Damborsky J; Valik D; Foretova L
Hum Mutat; 2001 Dec; 18(6):545. PubMed ID: 11748848
[TBL] [Abstract][Full Text] [Related]
24. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
25. BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect.
Muller D; Bonaiti-Pellié C; Abecassis J; Stoppa-Lyonnet D; Fricker JP
Fam Cancer; 2004; 3(1):15-20. PubMed ID: 15131401
[TBL] [Abstract][Full Text] [Related]
26. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI
BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160
[TBL] [Abstract][Full Text] [Related]
27. BRCA1 germline mutations in Indian familial breast cancer.
Valarmathi MT; A A; Deo SS; Shukla NK; Das SN
Hum Mutat; 2003 Jan; 21(1):98-9. PubMed ID: 12497638
[TBL] [Abstract][Full Text] [Related]
28. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
[TBL] [Abstract][Full Text] [Related]
29. Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer families.
Balz V; Prisack HB; Bier H; Bojar H
Cancer Genet Cytogenet; 2002 Oct; 138(2):120-7. PubMed ID: 12505256
[TBL] [Abstract][Full Text] [Related]
30. Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.
Ramus SJ; Harrington PA; Pye C; DiCioccio RA; Cox MJ; Garlinghouse-Jones K; Oakley-Girvan I; Jacobs IJ; Hardy RM; Whittemore AS; Ponder BA; Piver MS; Pharoah PD; Gayther SA
Hum Mutat; 2007 Dec; 28(12):1207-15. PubMed ID: 17688236
[TBL] [Abstract][Full Text] [Related]
31. BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.
Caligo MA; Ghimenti C; Cipollini G; Ricci S; Brunetti I; Marchetti V; Olsen R; Neuhausen S; Shattuck-Eidens D; Conte PF; Skolnick MH; Bevilacqua G
Oncogene; 1996 Oct; 13(7):1483-8. PubMed ID: 8875986
[TBL] [Abstract][Full Text] [Related]
32. Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families.
Kang HC; Kim IJ; Park JH; Kwon HJ; Won YJ; Heo SC; Lee SY; Kim KH; Shin Y; Noh DY; Yang DH; Choe KJ; Lee BH; King SB; Park JG
Hum Mutat; 2002 Sep; 20(3):235. PubMed ID: 12204006
[TBL] [Abstract][Full Text] [Related]
33. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
[TBL] [Abstract][Full Text] [Related]
34. Cancer predisposing BARD1 mutations in breast-ovarian cancer families.
Ratajska M; Antoszewska E; Piskorz A; Brozek I; Borg Å; Kusmierek H; Biernat W; Limon J
Breast Cancer Res Treat; 2012 Jan; 131(1):89-97. PubMed ID: 21344236
[TBL] [Abstract][Full Text] [Related]
35. Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families.
Xu CF; Chambers JA; Nicolai H; Brown MA; Hujeirat Y; Mohammed S; Hodgson S; Kelsell DP; Spurr NK; Bishop DT; Solomon E
Genes Chromosomes Cancer; 1997 Feb; 18(2):102-10. PubMed ID: 9115959
[TBL] [Abstract][Full Text] [Related]
36. Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer.
Greenman J; Mohammed S; Ellis D; Watts S; Scott G; Izatt L; Barnes D; Solomon E; Hodgson S; Mathew C
Genes Chromosomes Cancer; 1998 Mar; 21(3):244-9. PubMed ID: 9523200
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.
Delgado L; Fernández G; Grotiuz G; Cataldi S; González A; Lluveras N; Heguaburu M; Fresco R; Lens D; Sabini G; Muse IM
Breast Cancer Res Treat; 2011 Jul; 128(1):211-8. PubMed ID: 21190077
[TBL] [Abstract][Full Text] [Related]
38. Mechanism for survival of homozygous nonsense mutations in the tumor suppressor gene
Seo A; Steinberg-Shemer O; Unal S; Casadei S; Walsh T; Gumruk F; Shalev S; Shimamura A; Akarsu NA; Tamary H; King MC
Proc Natl Acad Sci U S A; 2018 May; 115(20):5241-5246. PubMed ID: 29712865
[No Abstract] [Full Text] [Related]
39. Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin.
Krivokuca A; Dragos VS; Stamatovic L; Blatnik A; Boljevic I; Stegel V; Rakobradovic J; Skerl P; Jovandic S; Krajc M; Magic MB; Novakovic S
Fam Cancer; 2018 Apr; 17(2):179-185. PubMed ID: 28685474
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.
De Leeneer K; Coene I; Crombez B; Simkens J; Van den Broecke R; Bols A; Stragier B; Vanhoutte I; De Paepe A; Poppe B; Claes K
Breast Cancer Res Treat; 2012 Feb; 132(1):87-95. PubMed ID: 21553119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
